Calumet, Inc. (NASDAQ: CLMT) ("Calumet") announced today that it plans to attend two investor conferences in December. On December 3rd and 4th, Calumet will attend the Bank of America Leveraged...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today...

Oral Late Breaker Presentation Summarizes Positive Results Including Successful Achievement of Study's Primary and Secondary Endpoints Data Support VK2809's Best-in-Class Profile Highlighted by...

The trial achieved both its primary endpoints, with semaglutide 2.4 mg demonstrating statistically significant and superior improvements in liver fibrosis with no worsening of steatohepatitis, as...

The Memorial and Joe DiMaggio Children's Hospital Foundations have appointed Kelley Morris, MHA, as President and CEO. With more than 25 years experience in healthcare philanthropy, operations,...